Publications
Original Article
A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer
Clinical Trials
2023
Authors:
Disis ML, Dang Y, Coveler AL, Childs JS, Higgins DM, Liu Y, Zhou J, Mackay S, Salazar LG
Journal:
Clinical Cancer Research
Volume:
29(17)
Page:
3362-3371
Pubmed:
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
2023
Authors:
Disis, ML, Adams, SF, Bajpai, J, Butler, MO, Curiel, T, Dodt, SA, Doherty, L, Emens, LA, Friedman, CF, Gatti-Mays, M, Geller, MA, Jazaeri, A, John, VS, Kurnit, KC, Liao, JB, Mahdi, H, Mills, A, Zsiros, E, and Odunsi, K
Journal:
Journal for Immunotherapy of Cancer
Volume:
11
Page:
Pubmed:
Original Article
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer
Antigen Discovery & Vaccines
2022
Authors:
Cecil, D.L., Curtis, B, Gad, E., Gormley, M, Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A., and Disis, M.L.
Journal:
Scientific Reports
Volume:
12
Page:
13618
Pubmed:
Original Article
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes
Antigen Discovery & Vaccines
2022
Authors:
Cecil DL, Gad EA, Corulli LR, Drovetto N, Lubet RA, Disis ML
Journal:
Cancer Prevention Research
Volume:
15(4)
Page:
225-231
Pubmed:
Original Article
Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon Cancer
Antigen Discovery & Vaccines
2022
Authors:
Waggie, KS, Corulli, LR, Cecil, D, Rodmaker, ER, Walsh, C, and Disis, ML
Journal:
Comparative Medicine
Volume:
72(5)
Page:
330-335
Pubmed:
Original Article
Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer
Clinical Trials
2022
Authors:
Disis, ML, Guthrie, KA, Liu, Y, Coveler, AL, Higgins, DM, Childs, JS, Dang, Y, and Salazar, LG
Journal:
JAMA Oncology
Volume:
9(1)
Page:
71-78
Pubmed:
Review Article
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Antigen Discovery & Vaccines
2021
Authors:
Antonarelli G, Corti C, Tarantino P, Ascione L, Cortes J, Romero P, Mittendorf EA, Disis ML, Curigliano G
Journal:
Annals of Oncology
Volume:
32(12)
Page:
1537-1551
Pubmed:
Original Article
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
2021
Authors:
Stanton, SE, Gad E, Ramos, E, Corulli LR, Annis, J, Katayama, H, Hamash S and Disis, ML
Journal:
Nature Partner Journals Breast Cancer
Volume:
7(1)
Page:
50
Pubmed:
Review Article
Differentiation and Regulation of T H Cells: A Balancing Act for Cancer Immunotherapy
General Immune Research
2021
Authors:
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, Corey Gallen, Amber Beyer, Colin Snyder, Gary Koski, Mary L Disis, Brian J Czerniecki, Krithika Kodumudi
Journal:
Frontiers in Immunology
Volume:
12
Page:
Pubmed:
Original Article
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Clinical Trials
2021
Authors:
John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Doreen M Higgins, Jennifer S Childs, Hania N Shakalia, Ron E Swensen, Sasha E Stanton, Anna V Tinker, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Mary L Disis, Barbara A Goff
Journal:
Journal for ImmunoTherapy of Cancer
Volume:
9(9)
Page:
Pubmed: